Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
192 participants
OBSERVATIONAL
2022-01-01
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diabetic Retinopathy Screening in General Practice
NCT05276778
Evaluation of Progression of Diabetic Retinopathy With Rapid Correction of Hyperglycemia
NCT02326259
Discovering Early Biomarkers in Circulating Endothelial Cells for Diabetes Complications by Single Cell RNA Sequencing
NCT05169502
Early Stage Retinal Abnormalities in Type 1 Diabetes, Screened With OCT Angiography.
NCT03496597
AI Screening for Diabetic Retinopathy
NCT05704491
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy Control
Blood draw
Blood samples will be collected via venipuncture
Diabetes but no retinopathy
Blood draw
Blood samples will be collected via venipuncture
Mild non proliferative diabetic retinopathy
Blood draw
Blood samples will be collected via venipuncture
Moderate non proliferative diabetic retinopathy
Blood draw
Blood samples will be collected via venipuncture
Severe non proliferative diabetic retinopathy
Blood draw
Blood samples will be collected via venipuncture
Proliferative diabetic retinopathy
Blood draw
Blood samples will be collected via venipuncture
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood draw
Blood samples will be collected via venipuncture
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Health status: established type 2 diabetes
* No history of panretinal photocoagulation (PRP)
* No history of treatment with intravitreal agents for past 12 months
Exclusion Criteria
* Acute or chronic infection (HIV, hepatitis B or C, tuberculosis)
* Cerebral vascular accident or cerebral vascular procedure
* Current pregnancy
* History of organ transplantation
* Presence of a graft (to avoid any effect of the graft)
* History of previous vitrectomy
* Subjects with a history of age-related macular degeneration age-related macular degeneration (AMD), glaucoma, uveitis, and branched or central vein occlusion.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indiana University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ashay Bhatwadekar, PhD, RPh
Associate Professor Ophthalmology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Spring Mill Clinic
Carmel, Indiana, United States
Eskenazi Eye Clinic
Indianapolis, Indiana, United States
Glick Eye Institute
Indianapolis, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11656
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.